Funder: American Association for Cancer Research
Due Dates: April 14, 2026 (Letter of Intent, 1:00 p.m. ET) | August 4, 2026 (Full application, by invitation, 1:00 p.m. ET)
Funding Amounts: $300,000 total over 3 years; no indirect costs allowed.
Summary: Supports early-career physician-scientists in oncology to advance innovative targeted therapeutics research, honoring Dr. José Baselga’s legacy.
Key Information: AACR Active membership in good standing is required by the LOI deadline.